The wound care nurse changes the dressing. The antibiotic course finishes. You elevate the foot, avoid pressure, follow every instruction. And six weeks later, the wound looks the same. Or worse.
At that point, the question is no longer about the wound. The question is about the blood supply that is supposed to be healing it.
Wound healing is fundamentally a circulatory process. When skin is damaged, the body sends oxygen, nutrients, immune cells, and repair proteins through the bloodstream to the site of the injury. That is how tissue rebuilds itself.
In patients with Peripheral Artery Disease, that delivery system is compromised. The arteries are too narrow to supply what the wound needs. No dressing, no antibiotic, and no offloading device can substitute for adequate blood flow. The wound is not failing to heal because the wrong treatment is being applied. It is failing to heal because the underlying circulation problem has not been addressed.
Any wound on the foot or lower leg of a patient with PAD or diabetes that has not shown clear, measurable improvement after four to six weeks of appropriate wound care warrants urgent vascular evaluation.
The 2024 ACC/AHA guidelines are explicit on this point: patients with PAD and wounds need a vascular assessment, not just ongoing wound management. The goal is to identify whether revascularization can improve perfusion to the wound site before the tissue damage becomes irreversible.
|
Warning signs that demand immediate vascular evaluation: A wound that is not improving after 4-6 weeks of appropriate care Blackening or darkening of the skin around the wound or on the toes Increasing pain at rest, especially at night A wound that smells, is producing significant discharge, or has signs of deep infection Any of these in a patient with known PAD or diabetes is a medical urgency. |
For some patients, the vascular assessment will confirm what they feared: the arterial disease has progressed too far for revascularization to help. The small vessels of the foot are too damaged. There is no suitable target for a bypass. No vessel accessible to a catheter.
This is called no-option CLTI, and it represents one of the most urgent unmet needs in vascular medicine. A 2025 study in Scientific Reports tracking real-world no-option CLTI patients found that at one year, 45% had undergone major amputation and 33% had died without effective treatment.
It is precisely this patient population for whom investigational research is being actively developed.
|
At this point, most patients are not looking for another opinion. They are looking for a reason not to give up. If your condition is not responding to current treatment... Some patients in this situation are exploring investigational approaches focused on restoring blood flow at the cellular level. Our guide on Your Own Blood Could Help Grow New Arteries. Here Is How. explores what the research is showing and who may be a candidate. |